ABSTRACT SUBMISSION

Organizers invite researchers, clinicians, and experts in the field of andrology to submit abstracts for presentation. Share your cutting-edge research and advancements in andrology by submitting abstracts that cover a wide spectrum of topics, from reproductive health and hormonal disorders to male infertility and sexual dysfunction.

Showcase your work to an international audience of andrology specialists, urologists, endocrinologists, and other allied healthcare professionals.

Abstracts should be submitted electronically through our online portal by the specified deadline to be considered for inclusion in the program.

Accepted presenters will have the chance to publish their abstracts in the congress proceedings published by Wiley.

Abstract submission and the role of the Submitter

• Abstracts must be submitted using the abstract submission system on the congress website. Abstracts submitted via any other channels will not be accepted.
• By completing the abstract submission, Submitters give full consent on behalf of the author and all co-authors to provide their data (such as affiliation) and results (abstracts will be published).
• Throughout the program organisation process, Organisers will communicate with the Submitter. Submitters are responsible for sharing any informaton from the Organisers with the Presenters.
• Submitters are requested to share any Presenter changes with the Organisers.
• Abstracts must be in English. Submitters must ensure that the abstract does not contain spelling or grammatical errors, as the abstract will be published as submitted.
• Only abstracts with a registered Presenter will be included in the final programme. Orals and posters without a Presenter registration will be considered withdrawn and removed from the programme 4 weeks before the event, without further notification.

Abstract format

• The maximum length of the abstract text is 500 words.
• The abstract is a plain text, without attached pictures or special characters, subscript or superscript formatting, or styles such as bold, italics, underlining, or all-capital letters.

Abstract content

• The authors are responsible and accountable for the contents of the abstract.
• The Organisers regard plagiarism as misconduct. All abstracts identified with plagiarised content will be rejected without review.
• Abstracts, including titles should not contain any sensitive information such as patient data.
• Abstracts, including titles should not contain brand names. Brand names and trade marks will be deleted without further notification to the Submitter.
• Abstracts, including titles should not contain political views. Such abstracts will be rejected.
• If the abstract involves clinical trials, patient data or animal studies, the authors are responsible for obtaining all necessary ethical approvals.
• Presenters are required to disclose any potential conflicts of interest.
• To protect sensitive information, please take into account that if unpublished research is uploaded to information-retaining AI-assisted tools, such as ChatGPT, confidentiality of your research cannot be assured.
• Submitters can access and change the abstracts until the final abstract submission deadline.
• Any changes after acceptance will be considered by the Program Organizing Committee.
• Submitters can indicate the preferred presentation format. However, accepted abstracts will be assigned a final presentation format by the Programme Organizing Committee.